| Literature DB >> 32396862 |
Diana Guallar1, Alejandro Fuentes-Iglesias2, Yara Souto2, Cristina Ameneiro2, Oscar Freire-Agulleiro3, Jose Angel Pardavila2, Adriana Escudero2, Vera Garcia-Outeiral2, Tiago Moreira4, Carmen Saenz5, Heng Xiong6, Dongbing Liu6, Shidi Xiao7, Yong Hou6, Kui Wu6, Daniel Torrecilla4, Jochen C Hartner8, Miguel G Blanco9, Leo J Lee10, Miguel López3, Carl R Walkley11, Jianlong Wang12, Miguel Fidalgo13.
Abstract
RNA editing of adenosine to inosine (A to I) is catalyzed by ADAR1 and dramatically alters the cellular transcriptome, although its functional roles in somatic cell reprogramming are largely unexplored. Here, we show that loss of ADAR1-mediated A-to-I editing disrupts mesenchymal-to-epithelial transition (MET) during induced pluripotent stem cell (iPSC) reprogramming and impedes acquisition of induced pluripotency. Using chemical and genetic approaches, we show that absence of ADAR1-dependent RNA editing induces aberrant innate immune responses through the double-stranded RNA (dsRNA) sensor MDA5, unleashing endoplasmic reticulum (ER) stress and hindering epithelial fate acquisition. We found that A-to-I editing impedes MDA5 sensing and sequestration of dsRNAs encoding membrane proteins, which promote ER homeostasis by activating the PERK-dependent unfolded protein response pathway to consequently facilitate MET. This study therefore establishes a critical role for ADAR1 and its A-to-I editing activity during cell fate transitions and delineates a key regulatory layer underlying MET to control efficient reprogramming.Entities:
Keywords: ADAR1; ER stress; MET; RNA A-to-I editing; UPR; iPSC; innate immune response; pluripotency; somatic cell reprogramming; subcellular localization
Mesh:
Substances:
Year: 2020 PMID: 32396862 PMCID: PMC7415614 DOI: 10.1016/j.stem.2020.04.016
Source DB: PubMed Journal: Cell Stem Cell ISSN: 1875-9777 Impact factor: 24.633